Shankar Narayanan

Chief Executive Officer, Real Chemistry

Shankar serves as Chief Executive Officer of Real Chemistry. He has over 25 years of experience at the center of services and technology within life sciences, with a background including senior executive roles at Equian, Cognizant, and McKinsey & Company, that provides a 360-degree understanding of the health ecosystem.

Jeff Rohwer

Head of Commercial Solutions, Real Chemistry

Jeff brings over 18 years of marketing experience in pharmaceuticals, biotechnology, medical device and digital health. An experienced and results-driven marketing strategist with a proven track record of growing businesses, developing omni-channel marketing initiatives across a diverse set of categories including oncology, diabetes, women’s health and cardiovascular diseases.

Rita Glaze-Rowe

President, Transformative Healthcare Markets, Real Chemistry

Rita brings 25 years of marketing, managed markets, pricing and reimbursement and strategic communications experience from her various roles across the healthcare industry. She specializes in bringing together the right mix of industry, content and media expertise to craft scientific and health value narratives across a range of industries, disciplines and publics. Rita is dedicated to understanding the current healthcare landscape from an access and reimbursement perspective

Leslie Isenegger

Practice Leader, Corporate Pricing & Public Affairs, Real Chemistry

Leslie Isenegger brings two decades of communications experience specializing in the integration of corporate reputation and risk mitigation, public policy and health economics. She regularly engages with clients to build communications platforms designed to establish corporate pricing principles, increase industry thought leadership around system value, and prepare clients for pricing and market access challenges.

Zack Kubow

Senior Group Director, Investor Relations, Real Chemistry

Zack Kubow brings 18+ years of investor relations and corporate communications experience, all within the healthcare industry. During his career, he has primarily focused on developing and executing strategic investor relations programs for private and public companies across a range of verticals within the medical technology, biotechnology, specialty pharmaceutical, life science tools/diagnostics and healthcare services sectors.

moderator

Mary Claire Duch

Group President, Integrated Communications, Real Chemistry

With 25 years of experience in the healthcare communications space, Mary Claire is a respected communications strategist who partners with clients to develop and implement communications plans that creatively advance business objectives. She has deep experience working with the industry's most cutting edge, innovative companies - effectively creating and executing corporate leadership initiatives, preparing for and managing issues, driving executive visibility, integrating investor and public relations programs, leading launch initiatives, navigating regulatory actions and data milestones and developing key stakeholder relationships.